Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Flutamide reduces hair growth better but has more side effects.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.